Form 4: Vertex Pharmaceuticals EVP David Altshuler Reports Stock Disposal
SEC Form 4 Filing
David Altshuler, EVP and Chief Scientific Officer of Vertex Pharmaceuticals, disposed of 2,142 shares of common stock on February 10, 2025, to cover tax obligations.
Summary
- On February 10, 2025, David Altshuler, the EVP and Chief Scientific Officer of Vertex Pharmaceuticals, disposed of 2,142 shares of common stock.
- The transaction was executed at a price of $467.98 per share.
- Following the transaction, Altshuler directly owns 43,099 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock disposal for tax obligations, which is neutral in sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of stock disposal transaction |
| 02/12/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.